Navigating the Complexities of Cell and Gene Therapy Supply Chains
Abstract: Cell and gene therapy supply chains are uniquely complex, requiring precise coordination, regulatory compliance, and robust logistics to ensure timely delivery of life-saving treatments. Developers face challenges such as temperature control, chain of custody, stakeholder alignment, and scalability. The article details best practices for supply chain management—including advanced planning, cold chain logistics, risk mitigation, technology adoption, and collaboration. It highlights how Catalent’s Case Management Services provide end-to-end support, streamlining operations and enabling therapies to reach patients efficiently and safely.